Literature DB >> 2400366

Conception in the resistant ovary syndrome occurring during hormone replacement therapy: a report of 2 cases.

A M Jequier1.   

Abstract

Two patients with resistant ovary syndrome are described. Both patients conceived while on hormone replacement therapy. Both women were taking the phasic preparation containing mestranol and norethisterone known as 'Menophase' (Syntex Pharmaceuticals Ltd). The possible mechanism of action of this type of hormone preparation in the induction of ovulation in patients with resistant ovary syndrome is discussed.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2400366     DOI： 10.1111/j.1479-828x.1990.tb03257.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN： 0004-8666            Impact factor:   2.100


  2 in total

1.  The live birth in a woman with resistant ovary syndrome after in vitro oocyte maturation and preimplantation genetic testing for aneuploidy.

Authors:  Nikolay Valerievich Kornilov; Marina Nikolaevna Pavlova; Pavel Pavlovich Yakovlev
Journal:  J Assist Reprod Genet       Date:  2021-01-26       Impact factor: 3.357

2.  Case report: Birth achieved after effective ovarian stimulation combined with dexamethasone in a patient with resistant ovary syndrome.

Authors:  Huiying Li; Tianli Chang; Hongbei Mu; Wenpei Xiang
Journal:  J Ovarian Res       Date:  2022-04-07       Impact factor: 4.234
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.